A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery

European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
M D KertaiD Poldermans

Abstract

To investigate the combined beneficial effect of statin and beta-blocker use on perioperative mortality and myocardial infarction (MI) in patients undergoing abdominal aortic aneurysm surgery (AAA). Patients undergoing elective AAA-surgery identified by clinical risk factors and dobutamine stress echocardiography (DSE) as being at high-risk often have considerable cardiac complication rate despite the use of beta-blockers. We studied 570 patients (mean age 69+/-9 years, 486 males) who underwent AAA-surgery between 1991 and 2001 at the Erasmus MC. Patients were evaluated for clinical risk factors (age>70 years, histories of MI, angina, diabetes mellitus, stroke, renal failure, heart failure and pulmonary disease), DSE, statin and beta-blocker use. The main outcome was a composite of perioperative mortality and MI within 30 days of surgery. Perioperative mortality or MI occurred in 51 (8.9%) patients. The incidence of the composite endpoint was significantly lower in statin users compared to nonusers (3.7% vs. 11.0%; crude odds ratio (OR): 0.31, 95% confidence interval (CI): 0.13-0.74; p=0.01). After correcting for other covariates, the association between statin use and reduced incidence of the composite endpoint remained unchan...Continue Reading

References

Oct 20, 1977·The New England Journal of Medicine·L GoldmanE E Slater
Jan 1, 1992·Circulation·D ReedT Hayashi
Jan 1, 1990·Anesthesiology·D T Mangano
Jul 1, 1986·Journal of General Internal Medicine·A S DetskyJ R Hilliard
Jul 4, 1998·The British Journal of Surgery·A W BradburyC V Ruckley
Apr 20, 2001·JAMA : the Journal of the American Medical Association·E BoersmaUNKNOWN DECREASE Study Group (Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiogrpahy)
Nov 17, 2001·European Journal of Internal Medicine·P L van HaelstJ W Tervaert
Jan 5, 2002·The New England Journal of Medicine·L A Fleisher, K A Eagle
Jan 29, 2002·Current Pharmaceutical Design·E M Kurowska
Aug 21, 2002·Circulation·Richard C PasternakUNKNOWN National Heart, Lung and Blood Institute
Apr 28, 2004·Journal of Vascular Surgery·Anai E S DurazzoBruno Caramelli

❮ Previous
Next ❯

Citations

Nov 3, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Nader N Boushra, Muhammad Muntazar
Jan 15, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Christiane P Tiefenbacher
Sep 2, 2005·Annals of Surgery·Shukri F KhuriUNKNOWN Participants in the VA National Surgical Quality Improvement Program
Jan 16, 2008·The Neurologist·Viktor Szeder, Michel T Torbey
Dec 25, 2007·Annals of Surgery·Trevor M Williams, Alden H Harken
May 29, 2009·Annals of Surgery·Martin DunkelgrunUNKNOWN Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group
Apr 16, 2011·Journal of the American Society of Nephrology : JASN·Amber O MolnarAmit X Garg
Jul 17, 2008·Vascular Health and Risk Management·Y C ChanM G Irwin
Aug 13, 2014·Anesthesiology Clinics·Ettore Crimi, Charles C Hill
Sep 4, 2009·The New England Journal of Medicine·Olaf SchoutenUNKNOWN Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group
Jun 22, 2011·Wiener klinische Wochenschrift·Matthias BockMarkus Paulmichl
Jul 18, 2009·Der Internist·N Diehm
Jun 19, 2010·Expert Opinion on Drug Safety·Michiel T VoûteDon Poldermans
Oct 24, 2013·Acta Anaesthesiologica Taiwanica : Official Journal of the Taiwan Society of Anesthesiologists·Shin-Yuan FangChen-Fuh Lam
Oct 24, 2015·Pharmacoepidemiology and Drug Safety·Elisabetta PatornoBrian T Bateman
Aug 15, 2012·Journal of Cardiothoracic and Vascular Anesthesia·Miklos D KertaiMihai V Podgoreanu
Oct 23, 2013·Journal of Vascular Surgery·Jorg L de BruinUNKNOWN DREAM Study Group
Jul 16, 2010·Medicina intensiva·M Ruiz-BailénR J Obra-Cuadra
Mar 26, 2009·Pharmacology & Therapeutics·Andrew LudmanDerek J Hausenloy
Sep 9, 2008·Seminars in Vascular Surgery·Russell H Samson
Nov 3, 2007·Progress in Cardiovascular Diseases·Nicolas DiehmIris Baumgartner
Jul 24, 2007·Annales Françaises D'anesthèsie Et De Rèanimation·N DantonV Piriou
Oct 19, 2005·Anaesthesia·B M BiccardP Foëx
Jan 18, 2006·Anaesthesia·B M BiccardP Foëx
May 8, 2007·Annales de cardiologie et d'angéiologie·D StephanE Fend
Apr 25, 2006·The Annals of Thoracic Surgery·Colleen Gorman KochEugene H Blackstone
May 9, 2006·The American Journal of Cardiology·Marleen A van de PolDon Poldermans
Mar 31, 2006·Journal of the American College of Surgeons·Ruth L BushCarol M Ashton
Feb 7, 2006·Annales Françaises D'anesthèsie Et De Rèanimation·M RauxR Isnard
Apr 4, 2007·Orvosi hetilap·Csiba László
Sep 5, 2006·Journal of the American College of Cardiology·Kim A Eagle, Wei C Lau
Aug 8, 2006·Journal of Vascular Surgery·Olaf SchoutenDon Poldermans
Oct 14, 2009·Journal of Vascular Surgery·Elliot L ChaikofUNKNOWN Society for Vascular Surgery
May 13, 2006·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·K I ParaskevasD P Mikhailidis
Apr 18, 2013·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·C P TwineI M Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.